KEGG: ecj:JW1814
STRING: 316385.ECDH10B_1963
YebO is an uncharacterized protein from Escherichia coli with a UniProt ID of P64499. The protein consists of 95 amino acids with the following sequence:
MNEVVNSGVMNIASLVVSVVVLLIGLILWFFINRASSRTNEQIELLEALLDQQKRQNALLRRLCEANEPEKADKKTVESQKSVEDEDIIRLVAER
The protein is encoded by the yebO gene (also known as b1825 or JW1814) and appears to be a membrane-associated protein based on its amino acid composition, which includes a hydrophobic stretch characteristic of transmembrane domains . Despite being classified as "uncharacterized," preliminary analyses suggest it may function in membrane organization or cellular transport processes.
E. coli expression systems are the most commonly utilized for producing recombinant YebO protein. Based on available research protocols, the following expression systems have demonstrated successful results:
| Expression System | Vector | Tag | Yield | Advantages | Limitations |
|---|---|---|---|---|---|
| E. coli BL21(DE3) | pET-based | N-terminal His | Moderate | Cost-effective, rapid growth | Potential inclusion body formation |
| E. coli Rosetta | pET-based | N-terminal His | Good | Enhanced translation of rare codons | More expensive |
| E. coli Shuffle | pET-based | N-terminal His | Variable | Better for disulfide bond formation | Slower growth rate |
The choice of expression system should be determined by experimental requirements, with E. coli BL21(DE3) serving as an appropriate starting point for most applications .
Recombinant YebO protein stability is significantly affected by storage conditions. For optimal results, the following guidelines should be followed:
After reconstitution, add 5-50% glycerol (final concentration) before aliquoting for long-term storage at -20°C/-80°C
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Avoid repeated freeze-thaw cycles as they significantly reduce protein activity
The protein appears to maintain stability in Tris/PBS-based buffer with 6% trehalose at pH 8.0, which should be considered when designing experimental protocols .
Purification of His-tagged YebO protein typically follows standard immobilized metal affinity chromatography (IMAC) protocols with specific optimizations:
Ni-NTA agarose columns perform well with binding buffers containing 20-50 mM imidazole to reduce non-specific binding
A step gradient elution protocol using 100 mM, 250 mM, and 500 mM imidazole yields the highest purity
Post-IMAC size exclusion chromatography may be necessary to achieve >95% purity
For membrane-associated proteins like YebO, addition of mild detergents (0.1% DDM or 0.5% CHAPS) in purification buffers improves yield
Western blotting using anti-His antibodies can confirm successful purification, with expected bands at approximately 10-11 kDa for the YebO protein .
While YebO remains largely uncharacterized, bioinformatic analysis of its sequence reveals several structural features that may provide insight into its function:
Hydrophobicity analysis indicates a transmembrane domain spanning residues 15-35, suggesting membrane integration
The C-terminal region (residues 60-95) contains charged residues arranged in a pattern consistent with amphipathic helices, potentially mediating protein-protein interactions
Secondary structure prediction algorithms suggest the presence of three α-helices and no β-sheets
These structural features place YebO in the category of small membrane proteins that may function in membrane organization, protein trafficking, or stress response pathways. Its relatively small size (95 amino acids) suggests a potential role as an accessory protein in larger complexes rather than as an enzymatic protein .
Optimizing YebO expression and purification for structural studies presents specific challenges due to its membrane association. The following methodological approaches have shown promise:
Expression optimization:
Induction with 0.1-0.5 mM IPTG at lower temperatures (16-20°C) for 16-20 hours
Co-expression with molecular chaperones (GroEL/GroES) to improve folding
Use of specialized E. coli strains like C41(DE3) or C43(DE3) designed for membrane protein expression
Purification refinements:
Inclusion of lipid nanodiscs or amphipols during purification to maintain native conformation
Detergent screening (DDM, LMNG, CHAPS) to identify optimal solubilization conditions
Buffer optimization with various salts (100-500 mM NaCl) and pH conditions (pH 6.5-8.5)
Quality assessment metrics:
Size-exclusion chromatography profiles showing monodisperse peaks
Thermal shift assays indicating stable protein folding
Negative stain electron microscopy to confirm protein homogeneity
These methodological refinements significantly enhance the likelihood of obtaining protein preparations suitable for crystallography, cryo-EM, or NMR structural studies .
Functional characterization of uncharacterized proteins like YebO requires a multi-faceted approach:
Protein-protein interaction studies:
Affinity purification coupled with mass spectrometry (AP-MS) to identify binding partners
Yeast two-hybrid screening against genomic libraries
Proximity labeling techniques (BioID, APEX) to identify neighboring proteins in vivo
Localization studies:
Fluorescent protein tagging for live-cell microscopy
Immunogold electron microscopy for precise subcellular localization
Fractionation studies coupled with western blotting
Phenotypic analysis:
Gene knockout/knockdown studies followed by comprehensive phenotypic assays
Complementation with mutant variants to identify critical residues
Growth under various stress conditions to identify conditional phenotypes
Integrated omics approaches:
Transcriptomics of knockout strains
Quantitative proteomics to identify affected pathways
Metabolomics to detect metabolic alterations
These methodological approaches should be applied systematically to gradually build a functional profile of YebO .
Based on limited data and structural predictions, YebO may interact with bacterial membrane systems in several specific ways:
Potential interactions with membrane protein complexes:
The conserved charged residues in the C-terminal domain might mediate electrostatic interactions with other membrane proteins
YebO may function as an accessory protein in larger complexes, similar to other small membrane proteins in E. coli
Possible roles in membrane organization:
The transmembrane domain might participate in membrane microdomain formation
YebO could potentially influence membrane curvature or rigidity in specific cellular regions
Interaction with the bacterial cytoskeleton:
Small membrane proteins often connect the membrane to cytoskeletal elements
YebO might serve as an anchor point for cytoskeletal proteins that maintain cell shape
Experimental approaches to test these hypotheses could include blue native PAGE, chemical crosslinking studies, and co-immunoprecipitation with candidate interacting proteins identified through bioinformatic predictions .
While specific data on yebO regulation is limited, uncharacterized proteins in E. coli often show condition-specific expression patterns. Based on general knowledge of bacterial gene regulation:
Stress response regulation:
Many membrane proteins show altered expression under membrane stress conditions
Monitoring yebO expression using qRT-PCR under various stressors (temperature, pH, osmotic pressure) could reveal regulatory patterns
Growth phase-dependent expression:
Small membrane proteins often show growth phase-dependent regulation
Analysis of yebO expression across different growth phases (lag, exponential, stationary) could provide functional insights
Potential transcriptional regulators:
Bioinformatic analysis of the yebO promoter region might reveal binding sites for known transcription factors
Chromatin immunoprecipitation (ChIP) studies could identify factors binding to the yebO regulatory regions
A comprehensive gene expression analysis under various conditions would significantly advance understanding of yebO's physiological role in E. coli .
When designing experiments to investigate YebO function, the following controls are essential:
Genetic controls:
Clean deletion mutant (ΔyebO)
Complementation with wild-type yebO
Complementation with tagged versions of yebO to confirm functionality
Empty vector controls for complementation studies
Protein expression controls:
Expression of unrelated membrane proteins of similar size
Expression of YebO with mutations in key predicted functional residues
Dose-dependent expression controls to differentiate between primary and secondary effects
Localization controls:
Co-localization with known membrane compartment markers
Controls for antibody specificity in immunolocalization studies
Fractionation quality controls using established compartment markers
These controls will help distinguish genuine YebO-specific effects from artifacts and general consequences of membrane protein overexpression or deletion .
Systematic analysis of YebO mutations requires careful experimental design:
Mutation strategy:
Alanine scanning of conserved residues
Charge reversal mutations for charged residues
Conservative and non-conservative substitutions at key positions
Truncation analysis to identify functional domains
Functional assessment approaches:
Complementation of knockout phenotypes
Protein stability and localization analysis
Interaction partner binding assays
In vitro activity assays (if applicable)
Data analysis framework:
Quantitative phenotype scoring
Structure-function correlation
Conservation analysis across bacterial species
Molecular dynamics simulations to predict mutation effects
This systematic approach will generate a comprehensive mutational landscape that can reveal functionally important regions and residues within the YebO protein .
Interpreting proteomic data for uncharacterized proteins like YebO requires specialized analytical approaches:
Differential abundance analysis:
Compare protein levels between wild-type and ΔyebO strains
Analyze affected pathways using enrichment analysis
Consider both direct and indirect effects based on magnitude and timing of changes
Protein-protein interaction data:
Prioritize interactions detected across multiple experimental approaches
Evaluate interaction strength using quantitative metrics from AP-MS
Validate key interactions using orthogonal methods
Post-translational modification analysis:
Identify modified residues in YebO under different conditions
Correlate modifications with functional changes
Compare modification patterns across growth conditions
These analytical approaches will help distinguish biologically relevant signals from experimental noise in complex proteomic datasets .
Several bioinformatic approaches can provide functional insights for YebO:
Sequence-based approaches:
Hidden Markov Model profiling against domain databases
Remote homology detection using PSI-BLAST and HHpred
Genetic context analysis (neighboring genes, operon structure)
Structure-based approaches:
Ab initio structure prediction using AlphaFold2 or RoseTTAFold
Structural comparison with characterized proteins
Binding site prediction based on surface properties
Integrated approaches:
Co-evolutionary analysis to identify functionally linked residues
Phylogenetic profiling to identify co-occurring genes
Metabolic modeling to predict pathway associations
These computational approaches, when integrated with experimental data, can significantly narrow the functional hypothesis space for uncharacterized proteins like YebO .
Based on current knowledge and available methodologies, several research directions show particular promise:
Systematic interactome mapping:
Comprehensive identification of protein-protein interactions
Mapping of genetic interactions through synthetic genetic arrays
Characterization of condition-specific interaction networks
Structural characterization:
High-resolution structure determination using cryo-EM or X-ray crystallography
Analysis of conformational dynamics using hydrogen-deuterium exchange mass spectrometry
In silico molecular dynamics simulations to predict functional motions
Systems-level functional analysis:
Multi-omics integration (transcriptomics, proteomics, metabolomics)
Phenotypic profiling under diverse environmental conditions
Evolutionary analysis across diverse bacterial species
These complementary approaches will collectively advance understanding of YebO's functional role in E. coli physiology and potentially reveal new aspects of bacterial membrane biology .
The scientific community can advance knowledge of uncharacterized proteins through several collaborative approaches:
Data sharing and standardization:
Deposition of experimental data in public repositories
Adoption of standardized experimental protocols
Development of community resources for functional annotation
Interdisciplinary collaboration:
Integration of structural biology, genetics, and systems biology approaches
Combining computational prediction with experimental validation
Engagement with researchers studying homologous proteins in diverse organisms
Technological innovation:
Development of new methods for membrane protein characterization
Application of emerging technologies like single-cell proteomics
Implementation of machine learning approaches for functional prediction